Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial

INTRODUCTION: Diabetes mellitus and diabetic nephropathy (DN) are prevalent and costly to manage. DN is the leading cause of end-stage kidney disease. Conventional therapy blocking the renin–angiotensin system has only achieved limited effect in preserving renal function. Recent observational data s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kam Wa, Ip, Tai Pang, Kwong, Alfred Siu Kei, Lui, Sing Leung, Chan, Gary Chi Wang, Cowling, Benjamin John, Yiu, Wai Han, Wong, Dickson Wai Leong, Liu, Yang, Feng, Yibin, Tan, Kathryn Choon Beng, Chan, Loretta Yuk Yee, Leung, Joseph Chi Kam, Lai, Kar Neng, Tang, Sydney Chi Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986085/
https://www.ncbi.nlm.nih.gov/pubmed/27496229
http://dx.doi.org/10.1136/bmjopen-2015-010741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986085/
https://www.ncbi.nlm.nih.gov/pubmed/27496229
http://dx.doi.org/10.1136/bmjopen-2015-010741

Ejemplares similares